Sogo Medical Co., Ltd. announced consolidated earnings results for the six months ended September 30, 2017. For the period, the group reported net sales of ¥66,491 million, operating income of ¥3,101 million, ordinary income of ¥3,118 million and profit attributable to owners of the parent of ¥1,839 million or ¥122.93 per share compared to net sales of ¥57,320 million, operating income of ¥2,432 million, ordinary income of ¥2,413 million and profit attributable to owners of the parent of ¥1,380 million or ¥92.24 per share reported in the same period last year. Income before income taxes was ¥3,067 million against ¥2,381 million reported last year.

For the year ending March 31, 2018, the group expected to report net sales of ¥135,566 million, operating income of ¥7,001 million, ordinary income of ¥7,016 million and profit attributable to owners of the parent of ¥4,029 million or ¥269.19 per share.

For the second quarter of fiscal year 2017, the company announced interim dividend of ¥27.50 per share compared to ¥25.00 per share paid last year. The dividend is payable on November 24, 2017.

For the full year 2017, the company expects to pay dividend of ¥27.50 per share compared to dividend of ¥25.00 per share declared last year.